How to Contact Senators About Jeff Sessions

Published on January 30, 2017 · Last updated July 28, 2020
Attorney General-designate, Sen. Jeff Sessions, R-Ala. is sworn in on Capitol Hill in Washington, Tuesday, Jan. 10, 2017, prior to testifying at his confirmation hearing before the Senate Judiciary Committee. (AP Photo/Andrew Harnik)

After a hectic first week of Donald Trump’s presidency, the Senate Judiciary Committee is scheduled to vote Tuesday on a motion to forward the nomination of Sen. Jeff Sessions (R-Ala.) for attorney general on to the full Senate.

Just a week ago, most Washington observers considered Sessions a shoo-in for confirmation. But after a spate of executive orders from the Trump administration that have raised legal questions and drawn fire from bipartisan members of congress, senators may give more scrutiny to the president’s nominees.

A staunch advocate of the war on drugs, Sessions remarked last year that “good people don’t smoke marijuana.” He praised a 1996 bill in Alabama that would’ve made drug dealers—including those selling cannabis—eligible for the death penalty. And he once joked that members of the Ku Klux Klan “were OK until I found out they smoked pot.”

In confirmation hearings earlier this month, Sessions stopped short of saying he’d target state-legal cannabis. Beyond emphasizing that the substance remains illegal under federal law, he  was noncommittal.

“Congress made the possession of marijuana in every state, and the distribution of it, an illegal act,” he told senators. “If that’s something that’s not desired any longer, Congress should pass a law to change the rule.”

Sessions struck a similar tone in written responses to senators’ questions. Asked whether he intends to follow the Cole memo, a Department of Justice document that set a policy of not interfering with state-legal cannabis, Sessions declined to commit to anything more than his intent to “review and evaluate” the policy.

“While I am generally familiar with the Cole memorandum, I am not privy to any internal Department of Justice data regarding the effectiveness of the policies contained within that memorandum,” he wrote. His job if confirmed, he wrote, “will be to enforce federal law, under which marijuana is currently a Schedule One controlled substance—defined as a drug with no currently  accepted medical use and a high potential for abuse.”

If approved, Sessions would have more control over federal cannabis policy than anyone but the president. Without pushback from Congress, he could target medical marijuana providers or even seek to overturn state cannabis laws, undoing decades of hard-won reform.

If Sessions’s nomination passes out of committee, it will be put to a vote by the full Senate. Want to make your voice heard on the issue? Below are the members of the Judiciary Committee and their office numbers.

Republican Members

Sen. Chuck Grassley (Iowa) —  Chairman
(202) 224-3744

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries

Sen. Orrin G. Hatch (Utah)
(202) 224-5251

Sen. Lindsey Graham (S.C.)
(202) 224-5972

Sen. John Cornyn (Texas)
(202) 224-2934

Sen. Michael S. Lee (Utah)
(202) 224-5444

Sen. Ted Cruz (Texas)
(202) 224-5922

Sen. Ben Sasse (Neb.)
(202) 224-4224

Sen. Jeff Flake (Ariz.)
(202) 224-4521

Sen. Mike Crapo (Idaho)
(202) 224-6142

Sen. Thom Tillis (N.C.)
(202) 224-6342

Sen. John Kennedy (La.)
(202) 224-4623

Democrat Members

Sen. Dianne Feinstein (Calif.) — Ranking member
(202) 224-3841

Sen. Patrick Leahy (Vt.)
(202) 224-4242

Sen. Dick Durbin (Ill.)
(202) 224-2152

Sen. Sheldon Whitehouse (R.I.)
(202) 224-2921

Sen. Amy Klobuchar (Minn.)
(202) 224-3244

Sen. Al Franken (Minn.)
(202) 224-5641

Sen. Christopher A. Coons (Del.)
(202) 224-5042

Sen. Richard Blumenthal (Conn.)
(202) 224-2823

Sen. Mazie Hirono (Hawaii)
(202) 224-6361

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Ben Adlin
Ben Adlin
Ben Adlin is a Seattle-based writer and editor who specializes in cannabis politics and law. He was a news editor for Leafly from 2015-2019. Follow him on Twitter: @badlin
View Ben Adlin's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.

© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.